Could targeting oxtyocin help treat opioid addiction?

Pills
Pills. Credit: Public Domain

A new review of published research indicates that the oxytocin system—a key player in social reward and stress regulation—is profoundly affected by opioid use. Therefore, it may be an important target for developing medications to treat opioid addiction and to prevent relapse.

"Social withdrawal is one of the key factors that can predispose people to heroin but is also a consequence of drug use," said Dr. Alexis Bailey, senior author of the British Journal of Pharmacology review.

"Given the benefits that social support programs like Alcoholics Anonymous and Narcotics Anonymous have in keeping addicts abstinent, current findings in the review suggest the use of the prosocial hormone oxytocin as a novel effective 'psycho-biological therapy' for the prevention of relapse to drug-use in drug dependent individuals. Therefore clinical studies assessing the efficacy of oxytocin-based pharmacotherapies in addiction are warranted."


Explore further

Opioid users treated in drug detention centers more likely to relapse

More information: British Journal of Pharmacology (2017). DOI: 10.1111/bph.13757
Journal information: British Journal of Pharmacology

Provided by Wiley
Citation: Could targeting oxtyocin help treat opioid addiction? (2017, April 5) retrieved 19 May 2019 from https://medicalxpress.com/news/2017-04-oxtyocin-opioid-addiction.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more